Home Journals Articles Updates About
CN
image
收藏切换
Research on risk assessment system of drug licensing transactions
收藏切换
PDF
Xiao-wen CHEN1, 2, Xia WU1, Bin ZHOU1, 3
Chinese Journal of New Drugs | 2023, 32(6) : 567 - 571
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(6): 567-571
Research on risk assessment system of drug licensing transactions
Full
Xiao-wen CHEN1, 2, Xia WU1, Bin ZHOU1, 3
Affiliations
  • 1China State Institute of Pharmaceutical Industry, Shanghai 201203, China
  • 2China National Pharmaceutical Industry Information Center, Shanghai 200040, China
  • 3Shanghai Shyndec Pharmaceutical Co., Ltd., Shanghai 200040, China
Published: 2023-03-30
Outline
收藏切换
Objective:

Drug licensing transactions are constrained by many legal provisions and face many uncertainties, which confuse investors to make decisions. A reasonable risk assessment system for drug licensing transactions will help licensors grasp risks more comprehensively and carry out corresponding prevention and control.

Methods:

The authors identified the risk factors through expert consultation, case analysis and other methods, and further split the risks of drug licensing transactions using the risk breakdown structure (RBS) method to obtain the risk assessment indicators of drug licensing transactions.

Results:

Eight secondary assessment indicators of drug licensing transaction risk, including strategic risk, patent and intellectual property risk, clause negotiation risk, R&D risk, cooperation risk with third parties, policy supervision risk, supply chain risk, and market risk, and 37 tertiary assessment indicators of drug licensing transaction risk were identified, and a diversified drug investment risk assessment system was constructed.

Conclusion:

There are many complex risks in the process of drug licensing transactions. The construction of a comprehensive and reasonable drug investment risk assessment system can help investors better identify and evaluate the risks of licensing projects before making decisions.

drug licensing transaction  /  risk assessment  /  system evaluation  /  investment risk
Xiao-wen CHEN, Xia WU, Bin ZHOU. Research on risk assessment system of drug licensing transactions[J]. Chinese Journal of New Drugs, 2023 , 32 (6) : 567 -571 .
Appendix
Less
Year 2023 volume 32 Issue 6
PDF
27
8
Cite this Article
BibTeX
Article Info
  • Online Date：2026-03-06
  • Published：2023-03-30
Article Data
Affiliations
History
  • Accepted：2023-02-06
Affiliations
    1China State Institute of Pharmaceutical Industry, Shanghai 201203, China
    2China National Pharmaceutical Industry Information Center, Shanghai 200040, China
    3Shanghai Shyndec Pharmaceutical Co., Ltd., Shanghai 200040, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House